Medicated Skin Care Products - Global Strategic Business Report - Product Image

Medicated Skin Care Products - Global Strategic Business Report

  • ID: 338929
  • Report
  • Region: Global
  • 342 Pages
  • Global Industry Analysts, Inc
1 of 4

FEATURED COMPANIES

  • Bayer AG (Germany)
  • EltaMD, Inc. (USA)
  • Johnson & Johnson (USA)
  • NEOCUTIS (USA)
  • Prestige Brands (USA)
  • SkinMedica, Inc. (USA)
  • MORE
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for Medicated Skin Care Products in US$ Million.

Company profiles are primarily based on public domain information including company URLs.

The report profiles 120 companies including many key and niche players such as:

- Advanced Dermatology Corporation
- Bayer AG
- Beiersdorf AG
- Chattem, Inc.
- Curatio Healthcare India Pvt. Ltd.
- EltaMD, Inc.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bayer AG (Germany)
  • EltaMD, Inc. (USA)
  • Johnson & Johnson (USA)
  • NEOCUTIS (USA)
  • Prestige Brands (USA)
  • SkinMedica, Inc. (USA)
  • MORE

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW
Medicated Skin Care Products: Medical Solutions for Skin Health Needs
Convergence of Beauty and Healthcare
Growth Drivers in a Nutshell
Growing Prevalence of Skin Diseases and the Unmet Treatment Needs: A Fundamental Growth Driver
Major Skin Diseases: Few Fast Facts
Global Market Outlook
Developed Markets: Traditional Revenue Contributors
Developing Countries Continue to Offer Significant Growth Opportunities
Table 1: Global Medicated Skin Care Products Market
Geographic Regions Ranked by CAGR (Value Sales) for 2015-2022: Asia-Pacific, Rest of World, Latin America, USA, Canada, Europe, and Japan (includes corresponding Graph/Chart)
Competitive Scenario
Leading Players in the Global Medicated Skin Care Products Market
Vendors Emphasize Collaborations
M&A Activity

2. MARKET TRENDS, ISSUES & DRIVERS
Increasing Focus on Wellness and Self-Care amidst Mounting Healthcare Costs Drive Healthy Market Growth
Health & Wellness Boosts Demand for Dermocosmetics
Aging Population and their Vulnerability to Age-Related Skin Changes: A Strong Growth Driver
Major Anti-Aging Ingredients of Cosmeceuticals
Popular Cosmeceutical Demographic Statistics of the Global Aging Populace: Unfurling the Market Potential
Table 2: Global Aging Population (in Thousands) by Age Group: 1975-2050 (includes corresponding Graph/Chart)
Table 3: Global Population by Age-Group: Percentage Change Over the Period 2010-2050 (includes corresponding Graph/Chart)
Table 4: Global Aging Population in Select Regions/ Countries: Population of 60+ Individuals in ‘000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart)
Booming Demand for Anti-Aging Skin Care Products Bodes Well for the Market
Common Skin Care Cosmeceuticals
Growing Prominence of Personalized Skin Care Prescriptions Benefit Market Penetration
Failure of Non-Prescription Products Drive Demand for Physician-Dispensed Skin Care Solutions
Medicated Skin Care Innovations: Spearheading Growth
Innovations for Acne
Innovations for Actinic Keratosis
Innovations for Tuberous Sclerosis Complex and Angiofibromas
Melasma Treatment Innovations
Onychomycosis Treatment Innovations
Innovations for Alopecia/Hair Loss
Stem Cell Technology: The New Frontier?
Intelligent Scanning for Identifying Beneficial Ingredients
Innovations in Anti-Aging Skin Care
Other Noteworthy Medicated Skin Care Innovations
Consumer Interest in Natural Ingredients Drive Demand for Natural and Organic Products
What’s Next in Ingredients?
Innovative Ingredients Gain Focus
Aesthetic Dermatology to Witness Sustained Growth
Favorable Trends in the Beauty Industry Spell Opportunities for Medicated Skin Care Market
Surging Popularity of Multi-Functional Products Promote Market Expansion
Sales of Hydroquinone-free Products Gain Momentum
Facial Wipes Offers Huge Untapped Growth Potential
Women: The Dominant Consumer Cluster for Medicated Skin Care Products
Physiological Differences Entail Need for Male Specific Products
Growing Prominence of Non-Invasive Skin Treatments Lends Traction to Market Demand
Increasing Environmental Pollution Drive Demand for Anti- Pollution Skin Care Products
Exponential Increase in Urban Population Promote Higher Demand for Medicated Skin Care
Table 5: World Urban Population in Thousands: 1950-2050P (includes corresponding Graph/Chart)
Table 6: Degree of Urbanization Worldwide: Urban Population as a Percentage of Total Population by Geographic Region for the Years 1990, 2014 & 2050 (includes corresponding Graph/Chart)

3. REGULATORY FRAMEWORK
The Food, Drug, and Cosmetic Act (FD&C Act)
The Concept of “Intended Use”
Skin Care Products Continue to Dodge Stringent US FDA Regulations
Regulatory Differences for Skin Care Products and Drugs
FDA getting into the Act
National Advertising Division Concentrates on Big Three

4. PRODUCT OVERVIEW

5. PRODUCT LAUNCHES/APPROVALS
ZO® Skin Health Unveils Oclipse® Daily-Use Sun Protection Product
Skinvisible Develops New Topical and Transdermal Cannabis Products
NeoStrata Launches ProSystem Retinol Peel
SkinFix Launches ExtraStrength Adult Skincare Product & Eczema Treatment for Kids
Skinbetter Science Introduces Clinical Skin Care Line
Galderma Receives Positive Opinion from EU Regulatory Agencies for EPIDUO
Adigica Health Launches BioClarity™ Acne Treatment
FDA Approves Differin Gel 0.1% for OTC Acne Treatment
Medimetriks Submits NDA for Impetigo Treatment Cream
Ceramax Cream by IntraDerm Pharmaceuticals Receives FDA Clearance
FDA Accepts Anacor’s NDA for Crisaborole Topical Ointment
Theraderm Launches New Anti-aging Skin Care System
Dapzone Gel by Allergan Receives FDA Approval for Acne Treatment
Bayer HealthCare Launches Finacea Foam for Rosacea Treatment
Galderma’s SOOLANTRA® (ivermectin) Cream Approved for Rosacea Patients
Skinvisible Pharmaceuticals Expands Patent Portfolio
Valeant Receives NEA Seal of Approval for CeraVe Baby Products
Galderma Launches Benzac® OTC Acne Solutions
LETI Laboratories’ AT4 System Launched in US

6. RECENT INDUSTRY ACTIVITY
ZO Skin Health Bags Global Rights to Suneva Medical’s ReFissa®
Galderma Conducts Phase 4 Clinical Studies of New Restylane® Products
CCA Industries Inks License Agreement with Ultimark Products
L'Oréal Purchases Valeant’s CeraVe, AcneFree and AMBI Skincare Brands
Otsuka Pharmaceutical to Construct New Facility
Shiseido Receives Regulatory Approval for New Retinol Formulation
Shiseido Acquires Gurwitch Products
Oculus Innovative Sciences Renames itself as Sonoma Pharmaceuticals
Taisho to Acquire KYORIN’s Dr. Program Business
Galderma Receives USFDA Approval of Restylane® Refyne and Restylane® Defyne
Moberg Pharma to Acquire Prestige Brands’ DermoPlast® Product Line
Nestlé Skin Health and Pinetree Care Group Collaborate on Skin Care Pilot Study
Cadila Acquires Skincare Brand Melgain from Issar Pharma
Chugai and Galderma Enter into Global License Agreement
Pfizer Acquires Anacor Pharmaceuticals
Nestlé Skin Health Enters into Agreement with Guthy-Renker LLC
Galderma Enters into Alliance with Maruho of Japan
Otsuka and Medimetriks Enter Into Licensing Agreement
Unilever to Acquire Clinical Skincare Brand Murad

7. FOCUS ON SELECT GLOBAL PLAYERS
Advanced Dermatology Corporation (USA)
Bayer AG (Germany)
Beiersdorf AG (Germany)
La Prairie Group AG (Switzerland)
Chattem, Inc. (USA)
Curatio Healthcare India Pvt. Ltd. (India)
Dr. med. Christine Schrammek Kosmetik GmbH & Co. KG (Germany)
EltaMD, Inc. (USA)
Episciences, Inc. (USA)
Galderma S.A. (Switzerland)
GlaxoSmithKline Plc (UK)
Stiefel Laboratories Inc. (USA)
IntraDerm™ Pharmaceuticals (USA)
Johnson & Johnson (USA)
Kao Corporation (Japan)
Laboratorios Leti SL. (Spain)
L'Oréal S.A. (France)
Medimetriks Pharmaceuticals, Inc. (USA)
Merz Pharma GmbH & Co. KGaA (Germany)
NEOCUTIS (USA)
Otsuka Pharmaceutical Co., Ltd. (Japan)
PCA Skin (USA)
Pfizer Inc. (USA)
Prestige Brands (USA)
Shiseido Co., Ltd. (Japan)
RéVive Skincare (USA)
SkinCeuticals (USA)
SkinMedica, Inc. (USA)
Skinvisible Pharmaceuticals, Inc. (USA)
Taisho Pharmaceuticals Co., Ltd. (Japan)
The Himalaya Drug Company (India)
Unilever NV (Netherlands)
Valeant Pharmaceuticals International, Inc. (Canada)
Obagi Medical Products, Inc. (USA)
Vivier Pharma (Canada)
ZO® Skin Health Inc. (USA)

8. GLOBAL MARKET PERSPECTIVE
Table 7: World Recent Past, Current & Future Analysis for Medicated Skin Care Products by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 8: World Historic Review for Medicated Skin Care Products by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 9: World 14-Year Perspective for Medicated Skin Care Products by Geographic Region
Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES
A.Market Analysis
Aging Population: A Significant Demand Booster for the Medicated Skin Care Market
Table 10: Aging Population in the US (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
Table 11: North American Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)
Baby-Boomers and Working Females Propel Demand for Medicated Skin Care Products
Natural Formulations Revive Growth in the Sluggish Skin Care Market
FDA Proposes Ban on Hydroquinone in Skin Care Products
Busy Lifestyles Spur Demand for Products with Anti-Stress Claims
Blemish Balms Attracts Attention
Competitive Landscape
Table 12: Leading Players in the US Dermatologicals Market (2016): Percentage Market Share Breakdown for Johnson & Johnson, Bayer, Sanofi, GSK, Pfizer, Prestige Brands and Others (includes corresponding Graph/Chart)
Product Launches
Strategic Corporate Developments
Select Key Players
B.Market Analytics
Table 13: US Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 14: US Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

2. CANADA
A.Market Analysis
Anti-Aging Cosmeceuticals: A High Growth Segment
Table 15: Aging Population in Canada (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
Competitive Landscape
Table 16: Leading Players in the Canadian Dermatologicals Market (2016): Percentage Market Share Breakdown for McNeil Consumer, Bayer, Prestige Brands, and Others (includes corresponding Graph/Chart)
Product Launch
Corporate Development
Select Key Players
B.Market Analytics
Table 17: Canadian Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 18: Canadian Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

3. JAPAN
A.Market Analysis
Aging Population, Growing Awareness and Rising Women Workforce Drives Market Demand
Table 19: Aging Population in Japan (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
Regulatory Overview
Competitive Landscape
Strategic Corporate Developments
Select Key Players
B.Market Analytics
Table 20: Japanese Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 21: Japanese Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4. EUROPE
A.Market Analysis
European Skin Care Market: A Macro Perspective
Despite Economic Woes, Anti-Aging Skin Care Market Continue to Witness Healthy Growth
Table 22: Aging Population in Europe by Region (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
B.Market Analytics
Table 23: European Recent Past, Current & Future Analysis for Medicated Skin Care Products by Geographic Region/Country
France, Germany, Italy, UK, Spain, Russia and Rest of European Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 24: European Historic Review for Medicated Skin Care Products by Geographic Region/Country
France, Germany, Italy, UK, Spain, Russia and Rest of European Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 25: European 14-Year Perspective for Medicated Skin Care Products by Geographic Region/Country
Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of European Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)
4a. FRANCE
A.Market Analysis
Competitive Landscape
Table 26: Leading Players in the French Dermatologicals Market (2016): Percentage Market Share Breakdown for Johnson & Johnson Santé Beauté, Laboratoires Pierre Fabre, Cooperation Pharmaceutique Francaise / Cooper and Others (includes corresponding Graph/Chart)
Key Player
B.Market Analytics
Table 27: French Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 28: French Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
4b. GERMANY
A.Market Analysis
Competitive Landscape
Table 29: Leading Players in the German Dermatologicals Market (2016): Percentage Market Share Breakdown for GSK, Bayer, and Others (includes corresponding Graph/Chart)
Product Launch
Select Key Players
B.Market Analytics
Table 30: German Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 31: German Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
4c. ITALY
Market Analysis
Table 32: Italian Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 33: Italian Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
4d. THE UNITED KINGDOM
A.Market Analysis
Rising Demand for OTC Medicines Drive Market Growth
Table 34: UK OTC Drug Market by Category (2017E): Percentage Breakdown of Value Sales for Analgesics, Cough and Cold Preparations, Medicated Skin Care Products, and Others (includes corresponding Graph/Chart)
Table 35: UK OTC Skin Care Market by Category (2017E): Percentage Breakdown of Value Sales for Antifungals, Antiseptic Products, Cold Sore Treatments, Cystitis Treatments, Deworming/Delice Treatments, Dry Skin Treatments, Feminine Lubricants, Hemorrhoid Treatments, Insect Bite Treatments, Medicated Skincare, Scalp/Hair Treatments, and Wart Treatments (includes corresponding Graph/Chart)
Competitive Landscape
Table 36: Leading Players in the UK Dermatologicals Market (2016): Percentage Market Share Breakdown for Bayer, GlaxoSmithKline, and Others (includes corresponding Graph/Chart)
Corporate Development
Key Player
B.Market Analytics
Table 37: UK Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 38: UK Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
4e. SPAIN
A.Market Analysis
Key Player
B.Market Analytics
Table 39: Spanish Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 40: Spanish Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
4f. RUSSIA
Market Analysis
Table 41: Russian Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 42: Russian Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
4g. REST OF EUROPE
A.Market Analysis
Product Launches
Strategic Corporate Developments
Select Key Players
B.Market Analytics
Table 43: Rest of Europe Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 44: Rest of Europe Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC
A.Market Analysis
Medicated Skin Brightening and Lightening Products: A High Growth Market
Asian Aesthetics Market
B.Market Analytics
Table 45: Asia-Pacific Recent Past, Current & Future Analysis for Medicated Skin Care Products by Geographic Region/Country
China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 46: Asia-Pacific Historic Review for Medicated Skin Care Products by Geographic Region/Country
China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 47: Asia-Pacific 14-Year Perspective for Medicated Skin Care Products by Geographic Region/Country
Percentage Breakdown of Dollar Sales for China, India, and Rest of Asia-Pacific Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)
5a. CHINA
A.Market Analysis
Overview
OTC Drug Market
Table 48: Chinese OTC Drug Market by Category (2017E): Percentage Breakdown of Value Sales for Analgesics, Gastrointestinal Drugs, Medicated Skincare Products, Traditional Medicines, and Others (includes corresponding Graph/Chart)
Corporate Development
B.Market Analytics
Table 49: Chinese Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 50: Chinese Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
5b. INDIA
A.Market Analysis
Overview
Corporate Development
Select Key Players
B.Market Analytics
Table 51: Indian Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 52: Indian Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
5c. REST OF ASIA PACIFIC
A.Market Analysis
Select Regional Markets
Australia: Aging Population Drives the Dermatologicals Market
Table 53: Aging Population in Australia (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
South Korea
Taiwan: Skin Problems of Modern Consumers Spurs Market Demand
Thailand: Thai Beauty Ingredients Gain Popularity in the West
B.Market Analytics
Table 55: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 56: Rest of Asia-Pacific Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

6. LATIN AMERICA
Market Analysis
Table 57: Latin American Recent Past, Current & Future Analysis for Medicated Skin Care Products by Geographic Region/Country
Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 58: Latin American Historic Review for Medicated Skin Care Products by Geographic Region/Country
Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 59: Latin American 14-Year Perspective for Medicated Skin Care Products by Geographic Region/Country
Percentage Breakdown of Dollar Sales for Brazil and Rest of Latin American Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)
6a. BRAZIL
A.Market Analysis
Relatively Lesser Share of Medicated Skin Care in OTC Sales Spell Opportunities
Table 60: Brazilian OTC Drug Market by Category (2017E): Percentage Breakdown of Value Sales for Analgesics, Cough and Cold Preparations, Medicated Skincare Products, Vitamins and Minerals, and Others (includes corresponding Graph/Chart)
B.Market Analytics
Table 61: Brazilian Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 62: Brazilian Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
6b. REST OF LATIN AMERICA
A.Market Analysis
Mexico: Competitive Landscape
Table 63: Leading Dermatologicals Players in Mexico (2016): Percentage Share Breakdown for Genomma Lab, Bayer de México, and Others (includes corresponding Graph/Chart)
B.Market Analytics
Table 64: Rest of Latin American Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 65: Rest of Latin American Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

7. REST OF WORLD
A.Market Analysis
United Arab Emirates: Increasing Consumer Willingness Drive Sales
Competitive Landscape
Table 66: Leading Dermatologicals Players in the UAE (2016): Percentage Share Breakdown for Bayer, J&J, GSK, and Others (includes corresponding Graph/Chart)
B.Market Analytics
Table 67: Rest of World Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 68: Rest of World Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE Total Companies Profiled: 120 (including Divisions/Subsidiaries 127)

  • The United States (58)
  • Canada (3)
  • Japan (11)
  • Europe (45)
    • France (7)
    • Germany (8)
    • The United Kingdom (8)
    • Spain (1)
    • Rest of Europe (21)
  • Asia-Pacific (Excluding Japan) (10)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Advanced Dermatology Corporation (USA)
  • Bayer AG (Germany)
  • Beiersdorf AG (Germany)
  • La Prairie Group AG (Switzerland)
  • Chattem, Inc. (USA)
  • Curatio Healthcare India Pvt. Ltd. (India)
  • Dr. med. Christine Schrammek Kosmetik GmbH & Co. KG (Germany)
  • EltaMD, Inc. (USA)
  • Episciences, Inc. (USA)
  • Galderma S.A. (Switzerland)
  • GlaxoSmithKline Plc (UK)
  • Stiefel Laboratories Inc. (USA)
  • IntraDerm™ Pharmaceuticals (USA)
  • Johnson & Johnson (USA)
  • Kao Corporation (Japan)
  • Laboratorios Leti SL. (Spain)
  • L'Oréal S.A. (France)
  • Medimetriks Pharmaceuticals, Inc. (USA)
  • Merz Pharma GmbH & Co. KGaA (Germany)
  • NEOCUTIS (USA)
  • Otsuka Pharmaceutical Co., Ltd. (Japan)
  • PCA Skin (USA)
  • Pfizer Inc. (USA)
  • Prestige Brands (USA)
  • Shiseido Co., Ltd. (Japan)
  • RéVive Skincare (USA)
  • SkinCeuticals (USA)
  • SkinMedica, Inc. (USA)
  • Skinvisible Pharmaceuticals, Inc. (USA)
  • Taisho Pharmaceuticals Co., Ltd. (Japan)
  • The Himalaya Drug Company (India)
  • Unilever NV (Netherlands)
  • Valeant Pharmaceuticals International, Inc. (Canada)
  • Obagi Medical Products, Inc. (USA)
  • Vivier Pharma (Canada)
  • ZO® Skin Health Inc. (USA)
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll